Abstract
Congestive heart failure is a major health problem in the diabetic. Diabetics have a high incidence of heart disease, including an increased incidence and severity of congestive heart failure than the non-diabetic. Progression to heart failure after an acute myocardial infarction is also more frequent in diabetics then non-diabetics. While atherosclerosis and ischemic injury are important contributing factors to this high in incidence of heart failure, another important factor is diabetes-induced changes within the heart itself. A prominent change that occurs in the diabetic is a switch in cardiac energy metabolism. Increases in fatty acid oxidation accompanied by decreases in glucose metabolism can result in the myocardium becoming almost entirely reliant on fatty acid oxidation as a source of energy. This switch in energy metabolism contributes to congestive heart failure by increasing the severity of injury following an acute myocardial infarction, and by having direct negative effects on contractile function. This paper will review the evidence linking alterations in energy metabolism to alterations in contractile function in the diabetic.
Similar content being viewed by others
References
Gotzsche O. Myocardial cell dysfunction in diabetes mellitus. Diabetes 1986;35:1158–1162.
Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta 1994;1213:263–276.
Lopaschuk GD. Alterations in myocardial fatty acid metabolism contribute to ischemic injury in the diabetic. Can J Cardiol 1989;5:315–320.
Fein FS, Sonnenblick. Diabetic cardiomyopathy. Progress in Cardiovascular Diseases 1985;4:255–270.
Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacologial Reviews 1992;44:103–150.
Borrow KM, Jaspan JB, Williams KA, Neumann A, Wolinski-Walley P, Lang RM. Myocardial mechanics in young adult patient with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. JACC 1990;15:1508–1517.
Hamby RI, Zoneraich, Sherman L. Diabetic cardiomyopathy. JAMA 1974;229:1749–1754.
Ledet T. Diabetic cardiomyopathy: quantitative histological studies of the heart from young juvenile diabetics. Acta Path Microbiol Scand 1976;84: 421–428.
Vered, Z, Battler A, Segal P, Liberman D, Yerushalmi Y, Berezin M, Meufeld H. Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (Diabetic cardiomyopathy. Am J Cardiol 1984;54:633–637.
Dillmann WH. Methyl palmoxirate increases Ca2+ myosin ATPase activity and changes myosin isoenzyme distribution in the diabetic rat heart. Am J Physiol 1985;248:E602-E605.
Dillmann WH. Myosin isoenzyme distribution and Ca2+ activated myosin ATPase activity in the rat heart influenced by fructose feeding and triiodothyronine. Endocrinology 1985;116:2160–2166.
Camps MA, Castello P, Munoz M, Monfar X, Testar M, Palacin A, Zorano A. Effect of diabetes and fasting on GLUT 4 (muscle/fat) glucose transporter expression in insulin sensitive tissues. Biochem J 1992;282: 765–772.
Heyliger CE, Rodrigues B, NcNeill JH. Effect of choline and methionine treatment on cardiac dysfunction of diabetic rats. Diabetes 1986;35:1152–1157.
Nicholl TA, Lopaschuk GD, McNeill JH. The effects of free fatty acids and dichloroacetate on the isolated working diabetic rat heart. Am J Physiol 1991; 261:H1053–H1059.
Wall SR, Lopaschuk GD. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rat. Biochim Biophys Acta 1989;1006:97–103.
Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8–13.
Bradley RF, Bryfogle JW. Survival of diabetic patients after myocardial infarction. Am J Med 1956;30:207–216.
Ulvenstam G, Aberg A, Bergstrand R, Johansson S, Pennert K, Vedin A, Wilhelmsen L, Wilhelmsson C. Long-term prognosis after myocardial infarction in men with diabetes. Diabetes 1985;34:787–792.
Stone PH, Muller JE, Hartwel T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, Braunwald E, Jaffe AS. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989;14:49–57.
Solang L, Malmerg K, Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 1999;20:789–795.
Garland PB, Randle PJ. Regulation of glucose uptake by muscle. X. Effects of alloxan diabetes, starvation, hypophysectomy and adrenalectomy and of fatty acids, ketonebodies and pyruvate on the glycerol output and concentrations of free fatty acids, longchain fatty acyl coenzyme A, glycerol phosphate and citrate cycle intermediates in rat hearts and diaphragm muscles. Biochem J 1970;93:678.
Lopaschuk GD, Russell JC. Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat. J Appl Physiol 1991;71:1302–1308.
Factor SM, Minase T, Sonnenblick EH. Clinical and morphological factors of human hypertensive-diabetic cardiomyopathies. Am Heart J 1980;99:446–458.
Weber JR. Left ventricular hypertrophy: its prime importance as a controllable risk factor. Am H J 1988;116:272–279.
Paternostro G, pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 1999;42:246–253.
Neely JR, Morgan HE. Relationship between carbohydrate metabolism and energy balance of heart muscle. Ann Rev Physiol 1974;36:413–459.
Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991;266:8162–8170.
McGarry JD, Woeltje KF, Kuwajima M, Foster DW. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase Diabetes 1989;5:271–284.
Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993;268:25836–25845.
Kim KH, Lopez-Casillas F, Bai DH, Luo X, Pape ME. Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB 1989;3:2250–2256.
Hardie DG, Corton J, Ching YP, Davies SP, Howley S. Regulation of lipid metabolism by the AMP-activated protein kinase. Biochem Soc Trans 1997;25:1229–1231.
Kudo N, Barr A, Barr R, Lopaschuk GD. 5'AMP-activated protein kinase inhibition of acetyl CoA carboxylase can explain the high rates of fatty acid oxidation in reperfused ischemic hearts. J Biol Chem 1995;270:17511–17520.
Kudo N, Gillespite JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuk GD. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1996;1301:67–75.
Dyck JRB, Kudo N, Barr AJ, Davies SP, Hardie DG, Lopaschuk GD. Phosphorylation control of cardiac acetyl CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. Biochem J 1999;261:1–8.
Lopaschuk GD, Gamble J. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol 1994;72:1101–1109.
Gamble J, Lopaschuk GD. Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism 1997;46:1270–1274.
Makinde A-O, Gamble J, Lopaschuk GD. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rate following birth in the newborn rabbit. Circ Res 1997;80:482–489.
Dyck JRB, Berthiaume LG, Thomas PD, Kantor PF, Barr AJ, Barr R, Singh D, Hopkins TA, Voilley N, Prentki M, Lopaschuk GD. Characterization of rat liver malonyl CoA decarboxylase and the study of its role in regulating fatty acid metabolism. Biochem J 2000;350:599–608.
Dyck JRB, Barr A, Barr R, Kolattukudy PE, Lopaschuk GD. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol 1998;44:H2122–H2129.
Sakamoto J, Barr RL, Kavanagh KM, Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol 2000;278:H1196–H1204.
Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/ lipid metabolism. Coronary Artery Disease 1996;7:116–123.
Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, Distefano S, Magnanini G, Muratori L, Rossi G, Zuarini A. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64;885–888.
Kesler I. Mortality experience in diabetic patients: a twenty-six year follow-up study. Am J Med 1971; 51:715–724.
Oswald B, Corcovan S, Yudkin JS. Prevalence and risks of hyperglycemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet 1984;1:1264–1267.
Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J 1986;293:917–922.
Partamian JO, Bradley RF. (Acute myocardial infarction in 258 cases of diabetes. N Engl J Med 1965; 273:455.
Stanley WC, Lopaschuk GD, Kivilo KM. Alterations in myocardial energy metabolism in streptozotocin diabetes. In: McNeill JH, ed. Experimental Models of Diabetes. CRC Press, 1999:19–38.
McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 1980;49:395–420.
Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 1996;79:940–948.
Liu B, El Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MV02 during reperfusion of ischemic hearts. Am J Physiol 1996;270:H72-H80.
Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Circ Res 1992;71:567–576.
Liedtke AJ, DeMaison L, Eggleston AL, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused mycoardium. Circ Res 1988;62:535–542.
Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990;66:546–553.
Saddik M, Lopaschuk GD. Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 1991;267:3825–3831.
Lopaschuk GD, Stanley WC. Manipulation of energy metabolism in the heart. Science and Medicine 1997;4:2–51.
Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985;54:466–472.
Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE. Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J 1984; 108:31–37.
Paulson D. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 1997;34:104–112.
Haider B, Ahmed SS, Moschos CB, Oldewurtel HA and Regan TJ. Myocardial function and coronary blood flow response to acute ischemia in chronic canine diabetes. Circ Res 1977;40:577–583.
Forrat R, Sebbage L, Wiernsperger N, Guidollet J, Renaud S, de Logeril M. Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res 1993;27:1908–1912.
Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993;88:1273–1278.
Ingebretsen CG, Moreau P, Hawelu-Johnson C, Ingebretsen WR Jr. Performance of diabetic rat hearts: effects of anoxia and increased work. Am J Physiol 1980;239:H614-H620.
Hearse DJ, Stewart DA, Chain EB. Diabetes and the survival and recovery of the anoxic myocadium. J Mol Cell Cardiol 1975;7:397–415.
Mokuda O, Sakamoto Y, Ikeda T, Mashiba H. Effects of anoxia and low free fatty acid on myocardial energy metabolism in streptozotocin-diabetic rats. Ann Nutr Metab 1990;34:259–265.
Savabi F, Kirsch A. Altered functional activity and anoxic tolerance in diabetic rat isolated aorta. Arch Biochem Biophys 1990;279:183–187.
Feuvray D, Idell-Wenger JA, Neely JR. Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 1979;44:322–329.
Lopaschuk GD, Spafford M. Response of isolated working hearts from acutely and chronically diabetic rats to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow. Circ Res 1989;65:378–387.
Lopaschuk GD, Spafford M. Acute insulin withdrawal contributes to ischemic heart failure in spontaneously diabetic BB Wistar rats. Can J Physiol Pharmacol 1990;68:462–466.
Broderick TL, Barr RL, Quinney HA, Lopaschuk GD. Acute insulin withdrawal from diabetic BB rats decreases myocardial glycolysis during low-flow ischemia. Metabolism 41:332–338.
Higuchi M, Ikema S, Matsuzaki T, Hirayama K, Sakanashi M. Effects of norepinephrine on hypoperfusion-rreperfusion injuries in hearts isolated from normal and diabetic rats. J Mol Cell Cardiol 1991;23:137–148.
Lopaschuk GD, Tsang H. Metabolism of palmitate in isolated working hearts from spontaneously diabetic “BB” Wistar rats. Circ Res 1987;61:853–858.
Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1994;1225:191–199.
Lopaschuk GD, Spafford MA. Glucose and palmitate oxidation during reperfusion of ischemic hearts from diabetic rats. Diabetic Heart 1991;1:451–464.
Pieper GM. Superoxide dismutase plus catalase improves post-ischaemic recovery in the diabetic heart. Cardiovas Res 1988;22:916–926.
Vogel WM, Apstein CS. Effects of alloxan-induced diabetes on ischemic reperfusion injury in rabbit hearts. Circ Res 1988;62;975–982.
Hekimian G, Feuvray D. Reduction of ischemiainduced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts. Diabetes 1986;35:906–910.
Tani M, Neely JR. Hearts from diabetic rats are more resistant to in vitro ischemia: Possible role of altered Ca2+ metabolism. Circ Res 1988;62:931–940.
Lopaschuk GD, Saddik M, Barr R, Huang L, Barker CC, Muzyka RA. Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. Am J Physiol 1992;263:E1046–E1053.
Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increase glucose metabolism and mechanical function following ischemia in diabetic rat heart. Cardiovas Res 1995;29:373–378.
Paulson DJ, Kopp SJ, Peace DG, Tow JP. Improved post-ischemic recovery of cardiac pump function in exercised trained diabetic rats. J Appl Physiol 1988;65:187–193.
Pieper GM, Gross GJ. Diabetes alters postischemic response to a prostacyclin mimetic. Am J Physiol 1989;256:H1353–H1360.
Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction- Relation to myocardial ischemia and infarct size. Am J Cardiol 1975;36:938–953.
Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Circ Res 1984;55:816–824.
Marban E, Koretsune Y, Corretti M, Chacko VP, Kusuoka H. Calcium and its role in myocardial cell injury during ischemia and reperfusion. Circulation 1989;80:IV-17–IV-22.
Tani M, Neely JR. Na+ accumulation increases Ca2+ overload and impairs function in anoxic rat heart. J Mol Cell Cardiol 1990;22:57–72.
Tani M. Mechanisms of Ca2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 1990;52: 543–559.
Tani M, Neely JR. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 1989;65:1045–1056.
Randle PJ, Newsholme EA, Garland PB. Regulation of glucose uptake by muscle. Effects of fatty acid, ketone bodies and pyruvate, and of alloxan diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphram muscle. Biochem J 1964; 93:652–665.
Khandoudi N, Bernard M, Cozzone P, Feuvray D. Intracellular pH and role of Na+ /H+ exchange during ischaemia and reperfusion of normal and diabetic rat hearts. Cardiovas Res 1990;24; 873–878.
Lagadic-Gossmann D, Chesnais JM, Feuvray D. Intracellular pH regulation in papillary muscle from steptozotocin diabetic rats: an ion-sensitive microelectrode study. Pflügers Arch 1988;414:613–617.
Pierce GN, Ramjiawan B, Dhalla NS, Ferrari R. Na+- H+ exchange in cardiac sarcolemmal vesicles isolated from diabetic rats. Am J Physiol 1990;258:H255–H261.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lopaschuk, G.D. Metabolic Abnormalities in the Diabetic Heart. Heart Fail Rev 7, 149–159 (2002). https://doi.org/10.1023/A:1015328625394
Issue Date:
DOI: https://doi.org/10.1023/A:1015328625394